Episode 288: April 2021 Preview Retinal Physician Preview || Complement Pathways for Dry AMD, Brolucizumab, Clinical Trial Adjustments with COVID-19, and PCV
Drs. Mrinali Gupta and Ajay Kuriyan join for a group discussion of the April 2021 edition of Retinal Physician with a focus on macular degeneration and clinical trials.
Relevant financial Disclosures: Dr. Gupta is a consultant for Allergan. Dr. Kuriyan is a consultant for Genentech, Regeneron, and Allergan and has received grant support from Genentech. Dr. Sridhar is a consultant for Regeneron and a unmasked treating physician for an Apellis trial.
You can now claim CME credits via the AAO website. Visit https://www.aao.org/browse-multimedia?filter=Audio&sub=ONE.ContentTypes.Audio.